News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG L.A. McKeown December 11, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes Shelley Wood September 28, 2016
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Daily News A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG Yael L. Maxwell May 13, 2016
News Daily News High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease Todd Neale August 17, 2015
News Industry News Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions June 05, 2015
News Daily News ‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes Caitlin E. Cox May 08, 2015